Status:
COMPLETED
Normotensive and Hypertensive Placental Abruptions
Lead Sponsor:
Hatice Akkaya
Conditions:
Abruptio Placentae; Affecting Fetus or Newborn
Eligibility:
FEMALE
18-45 years
Brief Summary
Placental abruption is a significant cause of both maternal morbidity and neonatal morbidity and mortality. Most abruptions accept to be related to a chronic placental disease process. Therefore, it i...
Detailed Description
Objective: We aimed to classify placental abruption according to hypertension status. Methods: This retrospective cohort designed study was conducted on 115 pregnant women with placental abruption. T...
Eligibility Criteria
Inclusion
- spontaneous,
- singleton pregnancies
- above 25 weeks of gestations with positive fetal cardiac activity
Exclusion
- multiple gestations,
- presence of fetal or maternal infection,
- chronic inflammatory diseases or connective tissue disorders
- history of myocardial infarction,
- thrombosis
- history of steroid drug usage.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT04449601
Start Date
January 1 2016
End Date
November 30 2017
Last Update
June 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.